Suggestions
Ingo Lehrke
CEO at Algiax & CBO at Tubulis
Professional Background
Ingo Lehrke is an accomplished Managing Director with extensive experience in the pharmaceuticals industry. His career spans various high-level managerial roles, where he has established a solid reputation for his strategic leadership and business acumen. Known for his entrepreneurial spirit, he also serves as a business angel and investor, contributing his wealth of knowledge to emerging ventures in the medical and pharmaceutical sectors. With a deep understanding of the complexities of pharmaceutics, medical devices, oncology, biotechnology, and intellectual property, Ingo has played a pivotal role in advancing organizations' business strategies and product developments.
Ingo's professional journey has seen him thrive in various top-tier positions, such as Chief Business Officer at Tubulis, where he has been influential in steering the company towards achieving its business objectives. He previously held the role of Chief Executive Officer at Algiax Pharmaceuticals, where his leadership was instrumental in navigating market challenges and fostering growth. His tenure as Managing Director at tesa Labtec GmbH and Labtec GmbH further underscores his capability in overseeing operations and driving business development efforts.
Notably, his background also includes a significant role as Director of Business Development at Labtec GmbH, where he successfully led initiatives that strengthened partnerships and expanded the company's market presence. Prior to this, he honed his skills as a Project Manager at Physicians World Europe, demonstrating an ability to manage complex projects and collaborate with diverse stakeholders.
Education and Achievements
Ingo Lehrke’s academic journey is a testament to his commitment to excellence and continuous improvement. He pursued his Ph.D. in Pharmacology at Heidelberg University, providing him with a robust foundation in the scientific principles that underpin the pharmaceutical industry. This technical expertise is complemented by his studies in Pharmaceutical Technology at Westfälische Wilhelms-Universität Münster, equipping him with the necessary skills to navigate the intricate landscape of drug development and regulatory compliance.
To further enhance his leadership capabilities, Ingo engaged in Executive Education focused on Leadership at SGBS Business School St. Gallen. This experience allowed him to refine his strategic thinking and management skills, preparing him to take on higher responsibilities within organizations. His pursuit of knowledge didn’t stop there; he also completed a program on Negotiation and Competitive Decision Making at the prestigious Harvard Business School, where he learned the nuances of negotiation tactics and decision-making strategies, invaluable for his roles in business development and management.
Additionally, Ingo holds a Diplom-Betriebswirt (BA) in Marketing & Finance from Berufsakademie Stuttgart, giving him a strong grounding in the principles of marketing and financial management, which are crucial in the competitive drug development landscape. His comprehensive educational background positions him as a well-rounded professional capable of integrating scientific knowledge with business insights.
Achievements
Throughout his career, Ingo has been recognized for his contributions to the pharmaceutical industry. His innovative approaches in managing complex projects have led to successful product launches and optimized operational efficiencies. As a Chief Business Officer at Tubulis, Ingo's strategic initiatives have been paramount in establishing the company as a leader in its niche, focusing on cutting-edge pharmaceutical solutions.
As Chief Executive Officer at Algiax Pharmaceuticals, he demonstrated exemplary leadership during a transformative period for the company, laying down a blueprint for sustainable growth and innovation. His ability to identify and capitalize on market opportunities while mitigating risks has been a hallmark of his leadership style.
Ingo's efforts in licensing and mergers & acquisitions (M&A) have significantly bolstered company portfolios under his guidance, reflecting his profound expertise in business development. His hands-on experience in navigating the complexities of business negotiations has equipped him to forge valuable partnerships and alliances, ultimately driving the success of the organizations he has been a part of.
His contributions extend beyond corporate achievements. As an investor and business angel, Ingo plays a vital role in nurturing the next generation of pharmaceutical innovations. His commitment to advancing the field through mentorship and investment not only helps spark new ideas but also promotes a culture of innovation and entrepreneurial spirit within the industry.